Narwhal Capital Management Abbott Laboratories Transaction History

Narwhal Capital Management

$1.09 Billion
Q3 2024

A detailed history of Narwhal Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Narwhal Capital Management holds 22,338 shares of ABT stock, worth $2.55 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

22,338

Previous 22,154 0.83%

Holding current value

$2.55 Million

Previous $2.3 Million 10.6%

% of portfolio

0.23%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$100.07 - $118.13 $18,412 - $21,735	184 Added 0.83%	22,338 $2.55 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $28,405 - $31,708	-282 Reduced 1.26%	22,154 $2.3 Million
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $931,467 - $1.03 Million	-8,505 Reduced 27.49%	22,436 $2.55 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $697,439 - $853,723	7,733 Added 33.32%	30,941 $3.41 Million
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $775,225 - $930,141	-8,115 Reduced 25.91%	23,208 $2.25 Million
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $455,324 - $507,326	-4,518 Reduced 12.61%	31,323 $3.41 Million
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $52,207 - $61,451	-539 Reduced 1.48%	35,841 $3.63 Million
Q4 2022 Jan 30, 2023	SELL	$95.06 - $111.52 $74,146 - $86,985	-780 Reduced 2.1%	36,380 $3.99 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $1.24 Million - $1.44 Million	-12,851 Reduced 25.7%	37,160 $3.6 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $1.08 Million - $1.31 Million	-10,598 Reduced 17.49%	50,011 $5.43 Million
Q1 2022 Apr 26, 2022	SELL	$114.02 - $139.04 $5.31 Million - $6.48 Million	-46,601 Reduced 43.47%	60,609 $7.17 Million
Q4 2021 Jan 26, 2022	SELL	$115.53 - $141.46 $883,111 - $1.08 Million	-7,644 Reduced 6.66%	107,210 $15.1 Million
Q3 2021 Oct 22, 2021	BUY	$116.66 - $129.06 $254,435 - $281,479	2,181 Added 1.94%	114,854 $13.6 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $167,888 - $197,629	1,587 Added 1.43%	112,673 $13.1 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $277,106 - $326,473	-2,546 Reduced 2.24%	111,086 $13.3 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $1.61 Million - $1.76 Million	15,380 Added 15.65%	113,632 $12.4 Million
Q3 2020 Oct 26, 2020	BUY	$91.64 - $111.29 $84,217 - $102,275	919 Added 0.94%	98,252 $10.7 Million
Q2 2020 Jul 22, 2020	BUY	$76.57 - $98.0 $69,602 - $89,082	909 Added 0.94%	97,333 $8.9 Million
Q1 2020 Apr 30, 2020	BUY	$62.82 - $91.86 $1.44 Million - $2.1 Million	22,894 Added 31.14%	96,424 $7.61 Million
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $24,416 - $27,181	311 Added 0.42%	73,530 $6.39 Million
Q3 2019 Oct 31, 2019	BUY	$81.84 - $88.74 $794,011 - $860,955	9,702 Added 15.27%	73,219 $6.13 Million
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $304,419 - $355,045	4,177 Added 7.04%	63,517 $5.34 Million
Q1 2019 Apr 12, 2019	SELL	$66.22 - $80.06 $166,543 - $201,350	-2,515 Reduced 4.07%	59,340 $4.74 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $43,597 - $49,389	-665 Reduced 1.06%	61,855 $4.47 Million
Q3 2018 Oct 23, 2018	SELL	$60.81 - $73.36 $6,081 - $7,336	-100 Reduced 0.16%	62,520 $4.59 Million
Q2 2018 Jul 19, 2018	BUY	$57.57 - $63.54 $171,846 - $189,666	2,985 Added 5.01%	62,620 $3.82 Million
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $769,098 - $869,558	13,668 Added 29.73%	59,635 $3.57 Million
Q4 2017 Jan 23, 2018	BUY	$53.68 - $57.47 $2.47 Million - $2.64 Million	45,967	45,967 $2.62 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.

Account

Narwhal Capital Management Abbott Laboratories Transaction History